BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22170686)

  • 1. The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells.
    Chien CC; Ko CH; Shen SC; Yang LY; Chen YC
    J Cell Physiol; 2012 Aug; 227(8):3128-37. PubMed ID: 22170686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells.
    Ko CH; Shen SC; Yang LY; Lin CW; Chen YC
    Int J Cancer; 2007 Oct; 121(8):1670-9. PubMed ID: 17597109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species.
    Chen YC; Shen SC; Tsai SH
    Biochim Biophys Acta; 2005 Apr; 1743(3):291-304. PubMed ID: 15843042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of telomerase and cyclooxygenase-2 in PDGF and FGF inhibition of C2-ceramide-induced apoptosis.
    Chien CC; Shen SC; Yang LY; Wu CY; Liau JS; Chen YC
    J Cell Physiol; 2009 Feb; 218(2):405-15. PubMed ID: 18932216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
    Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
    Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE₂ synthesis and COX-2 expression.
    Li M; Tan SY; Wang XF
    Oncol Rep; 2014 Dec; 32(6):2845-53. PubMed ID: 25322760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production.
    Shen SC; Ko CH; Tseng SW; Tsai SH; Chen YC
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):84-95. PubMed ID: 15163544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation.
    Chiu WT; Shen SC; Chow JM; Lin CW; Shia LT; Chen YC
    Neurobiol Dis; 2010 Jan; 37(1):118-29. PubMed ID: 19804834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis.
    Liou JY; Ellent DP; Lee S; Goldsby J; Ko BS; Matijevic N; Huang JC; Wu KK
    Stem Cells; 2007 May; 25(5):1096-103. PubMed ID: 17234991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death.
    Limami Y; Pinon A; Leger DY; Mousseau Y; Cook-Moreau J; Beneytout JL; Delage C; Liagre B; Simon A
    Biochimie; 2011 Apr; 93(4):749-57. PubMed ID: 21251952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
    Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells.
    Smartt HJ; Elder DJ; Hicks DJ; Williams NA; Paraskeva C
    Br J Cancer; 2003 Oct; 89(7):1358-65. PubMed ID: 14520472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mitochondrial apoptosis pathways in cutaneous squamous cell carcinoma cells by diclofenac/hyaluronic acid is related to upregulation of Bad as well as downregulation of Mcl-1 and Bcl-w.
    Rodust PM; Fecker LF; Stockfleth E; Eberle J
    Exp Dermatol; 2012 Jul; 21(7):520-5. PubMed ID: 22716247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H; Ye Y; Bai Z; Wang S
    Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells.
    Hwang JT; Kim YM; Surh YJ; Baik HW; Lee SK; Ha J; Park OJ
    Cancer Res; 2006 Oct; 66(20):10057-63. PubMed ID: 17047069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.